A recombinant factor VIII-Fc fusion protein (1), a recombinant factor IX - Fc fusion protein (2), a polyethylene glycol (PEG) - linked recombinant factor VIII (3), and a PEGylated factor IX (4) all have longer in vivo survival times and have been reported to control bleeding in hemophilia A and B.